您的购物车当前为空
别名 TG-0054 hydrobromide
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.

Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 990 | 6-8周 | |
| 10 mg | ¥ 1,580 | 6-8周 | |
| 25 mg | ¥ 2,850 | 6-8周 | |
| 50 mg | ¥ 4,640 | 6-8周 | |
| 100 mg | ¥ 7,170 | 6-8周 | |
| 200 mg | ¥ 11,800 | 6-8周 | |
| 500 mg | ¥ 23,800 | 6-8周 |
Burixafor hydrobromide 相关产品
| 产品描述 | Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization. |
| 体外活性 | Burixafor hydrobromide mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction [2]. |
| 别名 | TG-0054 hydrobromide |
| 分子量 | 647.644 |
| 分子式 | C27H52BrN8O3P |
| CAS No. | 1191450-19-7 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 50 mg/mL (65.02 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
H2O
| |||||||||||||||||||||||||||||||
评论内容